Iradimed Corp
(IRMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,542 | 523 | 1,930 | 1,463 | 1,202 |
| Depreciation Amortization | 55 | 21 | 130 | 98 | 65 |
| Accounts receivable | -295 | -175 | -397 | -130 | -98 |
| Accounts payable and accrued liabilities | 240 | 126 | 19 | 34 | -119 |
| Other Working Capital | 289 | -382 | -870 | -1,058 | -882 |
| Other Operating Activity | 417 | 349 | 658 | 300 | 353 |
| Operating Cash Flow | $2,248 | $462 | $1,470 | $707 | $522 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3 | -1 | -5 | -3 | -2 |
| PPE Investments | -236 | -8 | -160 | -144 | -38 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -14 |
| Other Investing Activity | 0 | 0 | -25 | 0 | -14 |
| Investing Cash Flow | $-239 | $-9 | $-190 | $-147 | $-54 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -210 | -6 | -510 | -214 | -3 |
| Financing Cash Flow | $-210 | $-6 | $-510 | $-214 | $-3 |
| Beginning Cash Position | 2,462 | 2,462 | 1,690 | 1,697 | 1,697 |
| End Cash Position | 4,261 | 2,909 | 2,460 | 2,043 | 2,163 |
| Net Cash Flow | $1,799 | $447 | $760 | $346 | $465 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,248 | 462 | 1,470 | 707 | 522 |
| Capital Expenditure | -236 | -8 | -192 | -144 | -38 |
| Free Cash Flow | 2,012 | 455 | 1,278 | 563 | 484 |